Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
Author(s) -
Ayesha Kamal,
Christopher Fain,
Angela Park,
Peiqi Wang,
Eduardo Gonzalez-Velez,
Daniel A. Leffler,
Susan Hutfless
Publication year - 2019
Publication title -
gastroenterology report
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 26
eISSN - 2304-1412
pISSN - 2052-0034
DOI - 10.1093/gastro/goz019
Subject(s) - medicine , sprue , angiotensin receptor blockers , enteropathy , adverse effect , gastroenterology , angiotensin converting enzyme , disease , blood pressure , biology , genetics , mold
Olmesartan, an angiotensin II receptor blocker (ARB), is associated with gastrointestinal symptoms resembling sprue-like enteropathy. Some have proposed that enteropathy may be a class effect rather than olmesartan-specific. We performed a systematic review to identify literature of sprue-like enteropathy for all ARBs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom